Higher chronic stress was linked to shorter survival after liver cancer treatment
A cohort study linked a combined stress index to survival after curative liver cancer treatment, without showing that stress caused the difference.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Patients classified as having higher chronic stress after curative treatment for hepatocellular carcinoma had significantly shorter disease-free and overall survival than those classified as having lower stress. This abstract-based cohort finding describes an association. It does not show that stress caused cancer to return, or that reducing stress would improve survival in this population.
The abstract does not report follow-up length, survival effect sizes or details of adjustment for other prognostic factors. It also does not describe independent validation of the newly constructed index.
How stress was classified
Hair cortisol and questionnaire scores were combined into a stress index using statistically selected thresholds. Researchers then compared disease-free survival—time without disease—and overall survival between the groups defined by that index.
What the accompanying review adds
The accompanying review located only 3 clinical trials about chronic stress and cancer recurrence. The abstract gives no detailed trial results, so it cannot establish that an intervention addressing stress would change cancer outcomes.
The original publication
Chronic stress impacts the prognosis of hepatocellular carcinoma patients after curative treatment by establishing a novel comprehensive classification: a cohort study and systematic review.
Wang X, Deng Y, Zheng P et al.
BMC Psychiatry · 2025
- PubMed ID
- 41057786
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.